Cargando…
A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study
Phenotypic plasticity, the ability of a living organism to respond to the environment, can lead to conclusions from experiments that are idiosyncratic to a particular environment. The level of environmental responsiveness can result in difficulties in reproducing studies from the same institute with...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148295/ https://www.ncbi.nlm.nih.gov/pubmed/32277094 http://dx.doi.org/10.1038/s41598-020-62509-7 |
_version_ | 1783520563951566848 |
---|---|
author | Karp, Natasha A. Wilson, Zena Stalker, Eve Mooney, Lorraine Lazic, Stanley E. Zhang, Bairu Hardaker, Elizabeth |
author_facet | Karp, Natasha A. Wilson, Zena Stalker, Eve Mooney, Lorraine Lazic, Stanley E. Zhang, Bairu Hardaker, Elizabeth |
author_sort | Karp, Natasha A. |
collection | PubMed |
description | Phenotypic plasticity, the ability of a living organism to respond to the environment, can lead to conclusions from experiments that are idiosyncratic to a particular environment. The level of environmental responsiveness can result in difficulties in reproducing studies from the same institute with the same standardised environment. Here we present a multi-batch approach to in-vivo studies to improve replicability of the results for a defined environment. These multi-batch experiments consist of small independent mini-experiments where the data are combined in an integrated data analysis to appropriately assess the treatment effect after accounting for the structure in the data. We demonstrate the method on two case studies with syngeneic tumour models which are challenging due to high variability both within and between studies. Through simulations and discussions, we explore several data analysis options and the optimum design that balances practical constraints of working with animals versus sensitivity and replicability. Through the increased confidence from the multi-batch design, we reduce the need to replicate the experiment, which can reduce the total number of animals used. |
format | Online Article Text |
id | pubmed-7148295 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-71482952020-04-15 A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study Karp, Natasha A. Wilson, Zena Stalker, Eve Mooney, Lorraine Lazic, Stanley E. Zhang, Bairu Hardaker, Elizabeth Sci Rep Article Phenotypic plasticity, the ability of a living organism to respond to the environment, can lead to conclusions from experiments that are idiosyncratic to a particular environment. The level of environmental responsiveness can result in difficulties in reproducing studies from the same institute with the same standardised environment. Here we present a multi-batch approach to in-vivo studies to improve replicability of the results for a defined environment. These multi-batch experiments consist of small independent mini-experiments where the data are combined in an integrated data analysis to appropriately assess the treatment effect after accounting for the structure in the data. We demonstrate the method on two case studies with syngeneic tumour models which are challenging due to high variability both within and between studies. Through simulations and discussions, we explore several data analysis options and the optimum design that balances practical constraints of working with animals versus sensitivity and replicability. Through the increased confidence from the multi-batch design, we reduce the need to replicate the experiment, which can reduce the total number of animals used. Nature Publishing Group UK 2020-04-10 /pmc/articles/PMC7148295/ /pubmed/32277094 http://dx.doi.org/10.1038/s41598-020-62509-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Karp, Natasha A. Wilson, Zena Stalker, Eve Mooney, Lorraine Lazic, Stanley E. Zhang, Bairu Hardaker, Elizabeth A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study |
title | A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study |
title_full | A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study |
title_fullStr | A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study |
title_full_unstemmed | A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study |
title_short | A multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study |
title_sort | multi-batch design to deliver robust estimates of efficacy and reduce animal use – a syngeneic tumour case study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148295/ https://www.ncbi.nlm.nih.gov/pubmed/32277094 http://dx.doi.org/10.1038/s41598-020-62509-7 |
work_keys_str_mv | AT karpnatashaa amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT wilsonzena amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT stalkereve amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT mooneylorraine amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT lazicstanleye amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT zhangbairu amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT hardakerelizabeth amultibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT karpnatashaa multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT wilsonzena multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT stalkereve multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT mooneylorraine multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT lazicstanleye multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT zhangbairu multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy AT hardakerelizabeth multibatchdesigntodeliverrobustestimatesofefficacyandreduceanimaluseasyngeneictumourcasestudy |